CRO-Solutions

What CRO-Solutions does

CRO-Solutions is a UK-based full-service contract research organization (CRO) headquartered in Salford, Manchester, providing integrated clinical trial services to biopharmaceutical and biotechnology sponsors. The company delivers a nine-module service platform spanning Clinical Project Management and Regulatory Services, Protocol Writing, Clinical Monitoring, Data Management, Pharmacovigilance, Medical Monitoring, Biostatistics, Medical Writing, and TMF Management, with each study led by a dedicated project manager from contract negotiation through regulatory submission and final reporting. The firm specializes in early-phase (Phase 1–2) clinical trials, with close operational ties to its sister company Medicines Evaluation Unit (MEU), a single-site Phase 1 clinical trial unit located at Wythenshawe Hospital in Manchester.

CRO-Solutions operates as a wholly-owned subsidiary of IQVIA (NYSE:IQV), the global clinical research services and healthcare intelligence provider. The company employs 51–100 people and operates on a bespoke, professional services revenue model with multi-year contracts and quote-based pricing tailored to individual sponsor project requirements. It is differentiated by tight KOL relationships in respiratory, dermatology, and cardiovascular medicine, CDISC-compliant data deliverables (CDASH, SDTM, ADaM), and boutique-level responsiveness paired with IQVIA's global infrastructure. Named customers include Evelo Biosciences, DICE Therapeutics, Arxx Therapeutics, Kinaset Therapeutics, and Theravance Biopharma, reflecting a focus on small-to-mid-cap enterprise biotech sponsors requiring flexible early-phase execution.

Go-to-market is via direct enterprise field sales supported by a professional website, LinkedIn presence, and industry event engagement. Geographic reach is described as global through IQVIA affiliation, though operational delivery is anchored in the UK. Revenue is not publicly disclosed and the company carries no independent AI/ML capability footprint, positioning it as a traditional services business whose competitive position rests on clinical expertise, IQVIA brand association, and integrated access to MEU's Phase 1 unit.

Name

CRO-Solutions

Legal name

CRO-Solutions

Website

https://crosolutions.co.uk

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

11–50 employees

Short description

CRO-Solutions is a UK-based, IQVIA-owned full-service clinical research organization providing integrated Phase 1–2 trial services — including project management, monitoring, data management, pharmacovigilance, biostatistics, and medical writing — to small and mid-cap biopharmaceutical and biotechnology sponsors.

Ownership category

akta.pro rank

Product category

Contract Research Organization (CRO) — Clinical Research Services

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical CROs (Phase I–IV) (HLAGAAAA)

akta.pro secondary industries

Clinical Data Management, Biostatistics & Statistical Programming CROs (HLAGAAAF), Medical Writing & Regulatory Submission Support CROs (HLAGAAAG), Pharmacovigilance, Risk Management & Medical Affairs CROs (HLAGAAAH)

Keywords

• Clinical research services
• Clinical trial management
• Contract research organization
• Pharmacovigilance services
• Biostatistics and medical writing

Headquarters

HQ city

Salford

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Clinical Research Services: CRO-Solutions generates revenue through providing comprehensive clinical research services to pharmaceutical and biotechnology companies. Services include Clinical Project Management, Protocol Writing, Clinical Monitoring, Data Management, Pharmacovigilance, Medical Monitoring, Biostatistics, Medical Writing, and TMF Management. The company operates on a bespoke, project-based model with dedicated project managers overseeing each study.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

CRO-Solutions is a Manchester-based contract research organization delivering full-service clinical trial support to biopharmaceutical and biotechnology sponsors. Each engagement is overseen by a dedicated project manager and covers clinical project management, protocol writing, clinical monitoring, data management, pharmacovigilance, medical monitoring, biostatistics, medical writing, and TMF management. The company operates as an IQVIA business with Phase 1 unit access through sister company Medicines Evaluation Unit (MEU).

Product overview

CRO-Solutions offers a full-service clinical research platform providing integrated clinical trial services. The unified offering consists of nine interconnected service modules: Clinical Project Management & Regulatory Services, Protocol Writing, Clinical Monitoring, Data Management, Pharmacovigilance, Medical Monitoring, Biostatistics, Medical Writing, and TMF Management & Clinical Trial Administration. Each study team is led by a dedicated Project Manager, enabling seamless coordination from contract negotiation through submission, study setup, data collection, analysis, and final reporting. The services are delivered as an integrated full-service solution tailored to individual client resource requirements.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Project Management & Regulatory Services Full-service clinical project management and regulatory support ensuring timely, compliant trial delivery from initiation to close-out with experienced project leaders and regulatory experts, designed for biopharmaceutical and biotechnology sponsors.
• Protocol Writing Expert clinical pharmacology support spanning protocol design, safety planning, pharmacovigilance, and patient recruitment, working alongside specialist clinicians and Key Opinion Leaders for biopharmaceutical sponsors.
• Clinical Monitoring Expert clinical monitoring services with both blinded and unblinded monitoring options, regulatory compliance, and detailed site feasibility evaluations ensuring robust trial oversight for biopharmaceutical sponsors.
• Data Management High-quality data management through expert-led teams from eCRF design to trial database lock, ensuring accurate, compliant, and timely data delivery with CDASH-compliant eCRF development for biopharmaceutical sponsors.
• Pharmacovigilance Comprehensive safety monitoring and strategic oversight from early-phase trials to large global studies, including ICSR handling, regulatory reporting, and DSUR preparation for biopharmaceutical sponsors.
• Medical Monitoring Experienced medical monitors providing regulatory compliance support, reviewing critical trial documents, resolving participant eligibility issues, and overseeing AE/SAE assessments for biopharmaceutical sponsors.
• Biostatistics Comprehensive statistical and programming expertise from study planning through regulatory-aligned documentation and CDISC-standardized outputs including SDTM and ADaM datasets for biopharmaceutical sponsors.
• Medical Writing Expert medical writing services producing clear, compliant clinical trial protocols, safety reports, white papers, and clinical study reports across diverse therapeutic areas for biopharmaceutical sponsors.
• TMF Management & Clinical Trial Administration Regulatory-ready Trial Master File management through meticulous setup, maintenance, and oversight ensuring smooth audits, inspections, and documentation flow across clinical trials for biopharmaceutical sponsors.

Named customers5 records

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Six partnerships are on record, tiered core and flagship.

• DICE TherapeuticscoreStrategic or Co-development Partner · 19 January 2024DICE Therapeutics partnered with CRO-Solutions for Phase 1 program support. CRO-Solutions provides strong project management team including Kristy Jamieson, Eve Billinge, and Caroline Crotty to support Phase 1 programs with partnership, flexibility, and problem-solving approach.
• Medicines Evaluation Unit (MEU)coreStrategic or Co-development Partner · 16 November 2023MEU is CRO-Solutions' sister company located opposite Wythenshawe Hospital. Together they provide integrated clinical trial services, combining CRO project management with Phase 1 clinical trial unit capabilities at a single site.
• Arxx TherapeuticscoreStrategic or Co-development Partner · 16 November 2023CRO-Solutions and MEU partnered with Arxx Therapeutics for their Phase 1 study. With their help, Arxx completed dosing of all healthy volunteers and successfully initiated the multiple ascending dose part in patients with psoriasis. The trial studies AX-202, a first-in-class anti-S100A4 monoclonal antibody.
• Kinaset TherapeuticscoreStrategic or Co-development Partner · 15 September 2021CRO-Solutions supports Kinaset's Phase 1b trial for KN-002 (inhaled pan-JAK inhibitor for severe asthma). The study is conducted at the Medicines Evaluation Unit in Manchester under Professor David Singh's guidance.
• Theravance BiopharmacoreStrategic or Co-development Partner · 3 July 2020CRO-Solutions supported Theravance Biopharma's Phase 2 study for hospitalized COVID-19 patients with acute lung injury in the UK. The study followed successful Phase 1 completion in healthy volunteers.
• IQVIAflagshipOthersCRO-Solutions is an IQVIA business (NYSE:IQV). IQVIA is a leading global provider of clinical research services, commercial insights, and healthcare intelligence to life sciences and healthcare industries.

Scale indicators1 record

Recent moves6 records

Expansion highlights4 records

Direct peers

• Ergomed: Ergomed is a UK-headquartered mid-size CRO offering clinical research, pharmacovigilance, and medical information services with particular strength in oncology and rare disease — the closest peer to CRO-Solutions in geography, size (similar headcount band), and specialty CRO positioning.
• Labcorp Drug Development (Covance): Labcorp's Drug Development segment (built on Covance) provides full-service clinical research including early-phase clinical solutions, data management, biostatistics, and central laboratory services — directly competing with CRO-Solutions' integrated Phase 1 + CRO offering.
• Parexel: Parexel is a global CRO offering Phase I–IV clinical trial management, biostatistics, data management, clinical monitoring, and regulatory/medical writing services — closely aligned with CRO-Solutions' full-service model.
• Syneos Health: Syneos Health is a global full-service biopharmaceutical solutions organization providing clinical development services (Phase I–IV, data management, biostatistics, medical writing, pharmacovigilance) — overlapping CRO-Solutions' core CRO platform across therapeutic areas.
• Medpace: Medpace is a mid-size global CRO focused on full-service clinical development for small-to-mid biotech sponsors, including clinical monitoring, data management, biostatistics, and medical writing — closely matching CRO-Solutions' biotech-customer profile and full-service scope.
• Charles River Laboratories: Charles River provides early-phase clinical research services alongside discovery, safety assessment, and biostatistics/data management — comparable to CRO-Solutions especially in early-phase oncology and specialty therapeutic-area CRO services.
• ICON plc: ICON plc is one of the world's largest full-service clinical research organizations, offering Phase I–IV clinical trial management, data management, biostatistics, and medical writing to biopharma sponsors — directly overlapping CRO-Solutions' full-service platform.
• Worldwide Clinical Trials: Worldwide Clinical Trials is a mid-size global CRO providing full-service clinical development including Phase I–IV, data management, biostatistics, medical writing, and pharmacovigilance — comparable to CRO-Solutions across service scope and mid-tier CRO positioning.

Broad incumbents

• Thermo Fisher Scientific (PPD): PPD (acquired by Thermo Fisher Scientific) is a top-tier global CRO providing Phase I–IV clinical development, data management, biostatistics, and pharmacovigilance — a broad incumbent offering overlapping full-service capabilities at much greater scale than CRO-Solutions.
• IQVIA: IQVIA (NYSE:IQV) is CRO-Solutions' parent company and the world's largest CRO, offering the same full-service clinical research capabilities (clinical monitoring, data management, biostatistics, pharmacovigilance, medical writing) at global scale — making it both owner and broadest competitive incumbent.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks7 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/meusolutions

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CRO-Solutions